Researchers have been excited about Retatrutide , a groundbreaking dual agonist showing promising results in early trials for size reduction . It functions by targeting both pathways : GLP-1 and GIP, these, when activated , assist influence hunger and enhance energy expenditure . Early findings demonstrate considerable weight management and poss… Read More